ARMP
Price
$2.38
Change
-$0.02 (-0.83%)
Updated
Jul 21 closing price
Capitalization
86.14M
22 days until earnings call
INNMF
Price
$0.20
Change
-$0.01 (-4.76%)
Updated
Jul 21 closing price
Capitalization
72.05M
Interact to see
Advertisement

ARMP vs INNMF

Header iconARMP vs INNMF Comparison
Open Charts ARMP vs INNMFBanner chart's image
Armata Pharmaceuticals
Price$2.38
Change-$0.02 (-0.83%)
Volume$10.65K
Capitalization86.14M
Amplia Therapeutics
Price$0.20
Change-$0.01 (-4.76%)
Volume$154.1K
Capitalization72.05M
ARMP vs INNMF Comparison Chart in %
Loading...
ARMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INNMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARMP vs. INNMF commentary
Jul 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARMP is a Buy and INNMF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 22, 2025
Stock price -- (ARMP: $2.38 vs. INNMF: $0.20)
Brand notoriety: ARMP and INNMF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARMP: 3% vs. INNMF: 260%
Market capitalization -- ARMP: $86.14M vs. INNMF: $72.05M
ARMP [@Biotechnology] is valued at $86.14M. INNMF’s [@Biotechnology] market capitalization is $72.05M. The market cap for tickers in the [@Biotechnology] industry ranges from $286.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARMP’s FA Score shows that 0 FA rating(s) are green whileINNMF’s FA Score has 0 green FA rating(s).

  • ARMP’s FA Score: 0 green, 5 red.
  • INNMF’s FA Score: 0 green, 5 red.
According to our system of comparison, INNMF is a better buy in the long-term than ARMP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARMP’s TA Score shows that 4 TA indicator(s) are bullish while INNMF’s TA Score has 4 bullish TA indicator(s).

  • ARMP’s TA Score: 4 bullish, 4 bearish.
  • INNMF’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ARMP is a better buy in the short-term than INNMF.

Price Growth

ARMP (@Biotechnology) experienced а +3.93% price change this week, while INNMF (@Biotechnology) price change was -9.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.39%. For the same industry, the average monthly price growth was +15.71%, and the average quarterly price growth was +33.77%.

Reported Earning Dates

ARMP is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARMP($86.1M) has a higher market cap than INNMF($72M). INNMF YTD gains are higher at: 384.262 vs. ARMP (28.649). ARMP has higher annual earnings (EBITDA): 13.5M vs. INNMF (-6.43M). ARMP has more cash in the bank: 11.7M vs. INNMF (10.9M). INNMF has less debt than ARMP: INNMF (13.9K) vs ARMP (135M).
ARMPINNMFARMP / INNMF
Capitalization86.1M72M120%
EBITDA13.5M-6.43M-210%
Gain YTD28.649384.2627%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash11.7M10.9M107%
Total Debt135M13.9K971,223%
FUNDAMENTALS RATINGS
ARMP vs INNMF: Fundamental Ratings
ARMP
INNMF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
52
Fair valued
PROFIT vs RISK RATING
1..100
10064
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
3834
P/E GROWTH RATING
1..100
92100
SEASONALITY SCORE
1..100
6550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

INNMF's Valuation (52) in the null industry is in the same range as ARMP (80) in the Biotechnology industry. This means that INNMF’s stock grew similarly to ARMP’s over the last 12 months.

INNMF's Profit vs Risk Rating (64) in the null industry is somewhat better than the same rating for ARMP (100) in the Biotechnology industry. This means that INNMF’s stock grew somewhat faster than ARMP’s over the last 12 months.

INNMF's SMR Rating (97) in the null industry is in the same range as ARMP (100) in the Biotechnology industry. This means that INNMF’s stock grew similarly to ARMP’s over the last 12 months.

INNMF's Price Growth Rating (34) in the null industry is in the same range as ARMP (38) in the Biotechnology industry. This means that INNMF’s stock grew similarly to ARMP’s over the last 12 months.

ARMP's P/E Growth Rating (92) in the Biotechnology industry is in the same range as INNMF (100) in the null industry. This means that ARMP’s stock grew similarly to INNMF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARMPINNMF
RSI
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 5 days ago
83%
Momentum
ODDS (%)
Bullish Trend 5 days ago
90%
N/A
MACD
ODDS (%)
Bullish Trend 5 days ago
78%
Bearish Trend 5 days ago
64%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
83%
Bearish Trend 5 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
85%
Bullish Trend 5 days ago
73%
Advances
ODDS (%)
Bullish Trend 8 days ago
85%
Bullish Trend 15 days ago
64%
Declines
ODDS (%)
N/A
Bearish Trend 9 days ago
70%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
89%
Aroon
ODDS (%)
Bullish Trend 5 days ago
85%
Bullish Trend 5 days ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
ARMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INNMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HLFFF10.05N/A
N/A
Hellofresh SE
BTGGF63.22N/A
N/A
Bitcoin Group SE
ASGLY5.92-0.06
-1.00%
AGC Inc.
CMWAY116.05-2.15
-1.82%
Commonwealth Bank of Australia
CNRCF0.05N/A
-6.40%
CANTER RES CORP.

ARMP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARMP has been loosely correlated with PTIX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ARMP jumps, then PTIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARMP
1D Price
Change %
ARMP100%
-0.83%
PTIX - ARMP
45%
Loosely correlated
-7.02%
CTNM - ARMP
32%
Poorly correlated
+29.89%
BOLT - ARMP
31%
Poorly correlated
+3.71%
TNGX - ARMP
31%
Poorly correlated
N/A
FGHQF - ARMP
25%
Poorly correlated
N/A
More

INNMF and

Correlation & Price change

A.I.dvisor tells us that INNMF and CGEN have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INNMF and CGEN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INNMF
1D Price
Change %
INNMF100%
-4.76%
CGEN - INNMF
24%
Poorly correlated
-1.95%
HOFBF - INNMF
22%
Poorly correlated
N/A
EXEL - INNMF
21%
Poorly correlated
-0.47%
ARMP - INNMF
21%
Poorly correlated
-0.83%
KRRO - INNMF
20%
Poorly correlated
-2.41%
More